Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-06 · accession 0001209191-22-060587 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-09 | 2022-12-06 | TXMD | Walker Marlan D | GC | M - OptEx | $0.00 | +2,554 | 6,189 | +70% | $0 |
| D | 2022-12-09 | 2022-12-06 | TXMD | Walker Marlan D | GC | S - Sale+OE | $4.95 | -1,048 | 6,685 | -14% | -$5,188 |
| DM | 2022-12-09 | 2022-12-06 | TXMD | Walker Marlan D | GC | M - OptEx | $0.00 | -2,554 | 770 | -77% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-06 | M | A | 1,156 | $0.00 | 7,345 | D | — | — | (F1) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs). |
| 2 | Common | Common Stock | 2022-12-06 | S | D | 1,048 | $4.95 | 6,685 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $4.66 through $5.41, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth. |
| 3 | Common | Common Stock | 2022-12-06 | M | A | 388 | $0.00 | 7,733 | D | — | — | (F1) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs). |
| 4 | Common | Common Stock | 2022-12-06 | M | A | 1,010 | $0.00 | 6,189 | D | — | — | (F1) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs). |
| 5 | Derivative | Restricted Stock Unit | 2022-12-06 | M | D | 1,010 | $0.00 | 1,010 | D | $0.00 · — to — | 1,010 Common Stock | (F1) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs). (F4) The RSUs vest in three equal installments annually, becoming fully vested on March 30, 2023. |
| 6 | Derivative | Restricted Stock Unit | 2022-12-06 | M | D | 1,156 | $0.00 | 2,311 | D | $0.00 · — to — | 1,156 Common Stock | (F1) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs). (F5) The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024. |
| 7 | Derivative | Restricted Stock Unit | 2022-12-06 | M | D | 388 | $0.00 | 770 | D | $0.00 · — to — | 388 Common Stock | (F1) Each RSU represents a contingent right to receive one share of issuer common stock upon settlement. On December 6, 2022, the reporting person received 2,554 shares of issuer common stock in settlement of restricted stock units (RSUs). (F6) Subject to the reporting person's continuous service, the RSUs will vest in three equal installments annually, beginning September 29, 2022, becoming fully vested on September 29, 2024. |